A meditation app beloved by Wall Street and Silicon Valley has unveiled a new plan to be more like a drug
Business Insider -

Headspace, a favorite meditation app of Wall Street and Silicon Valley, has launched a new subsidiary charged with developing a suite of prescription-level apps for a range of health conditions.

Called Headspace Health, the subsidiary is starting clinical trials on its first product this summer.

Headspace Health hopes to get Food and Drug Administration approval for the new digital health tool within two years.

The $250 million mindfulness app company Headspace has big plans to turn...

Loading...

Related Articles